Older adults with limited life expectancy are frequently screened for cancer even though it exposes them to risks of screening with minimal benefit. Patient preferences may be an important contributor to continued screening.
C ancer screening in older adults with limited life expectancy may inappropriately subject them to short-term harms when chance of benefit is minimal. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Research and clinical practice guidelines recommend incorporating life expectancy to inform cancer screening. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Specifically, several Choosing Wisely recommendations mention that clinicians should not routinely screen for cancer among patients with limited life expectancy. [13] [14] [15] [16] However, many older adults with limited life expectancy still frequently receive cancer screening, [17] [18] [19] [20] [21] [22] with screening rate as high as 55% in one study.
17
Only a few small studies have explored older adults' views on stopping cancer screening. The results suggest that some older adults may be strongly enthusiastic about cancer screening [23] [24] [25] [26] [27] and may not always consider life expectancy important in the screening decision. 25, 26 In one survey study 25 30 showed that primary care clinicians often considered that their patients had limited life expectancy but were hesitant to recommend against cancer screening. Clinicians were concerned that patients may react negatively to screening cessation and also struggled with discussing life expectancy.
30
In this context, patient perspectives and preferences about stopping cancer screening among those with limited life expectancy are critical to address clinician concerns, inform screening discussions, and help align clinical guidelines with patient preference. Because relatively little is known about this area, we use qualitative methods in this study to explore the range of perspectives from older adults to generate hypotheses. We aim to examine community-dwelling older adults' perspectives on the decision to stop cancer screening when life expectancy is limited and to identify their preferences for how clinicians should communicate recommendations to cease cancer screening.
Methods

Design and Study Setting
This was a qualitative study in which semistructured interviews lasting 30 to 60 minutes were conducted with community-dwelling older adults (≥65 years). Participants were recruited from 4 clinical programs affiliated with an urban academic medical center, including a geriatric ambulatory clinic, a general internal medicine ambulatory clinic, a house-call program for homebound older adults, and a Program of AllInclusive Care for the Elderly (PACE). This project was approved by a Johns Hopkins School of Medicine institutional review board.
Participants and Recruitment
Older adults were eligible to participate if they were 65 years or older, English-speaking, and able to provide informed consent. Because cognitive impairment affects the risk-benefit ratio of cancer screening, 31 we sought to include those with cognitive impairment as long as the person could still participate meaningfully in the interview and provide written informed consent. For potential participants who had a diagnosis of cognitive impairment or dementia and were interested in the study, we consulted with the person's family members and/or clinician to ensure that the person could provide written informed consent and could participate in a 30-to 60-minute interview. We used maximum variation sampling (targeting a wide range of diverse participants) to recruit community-dwelling older adults with a wide range of age, health and functional status, and life expectancies.
32,33 We purposefully recruited from 4 different clinical programs to include older adults in ambulatory clinics and those who were home-bound (housecall) and/or had limitations in daily activities (PACE). We also asked clinicians from all 4 clinical programs to help identify potential participants. Recruitment stopped when theme saturation in the data was reached, 32 as described in subsequent section. Each participant was provided a $50 gift card, and parking voucher when needed.
Interview Guide
The interview guide (in the Supplement) was developed and iteratively revised during pretesting with 10 older adults who were not included in the study. At the beginning of the interview, we provided a brief overview of the benefits and potential harms of cancer screening, using breast and/or prostate and colorectal cancer screenings as examples. We chose these examples because they are routinely recommended in older adults, and overscreening has been shown to occur. [3] [4] [5] [6] [17] [18] [19] [20] [21] [22] We explicitly mentioned that it may take up to 10 years before a cancer grows to the point of causing health problems, so that someone who will not live 10 years may not benefit and may be harmed from screening. 2, 6 We then asked questions about 2 domains: decision-making and communication.
In the decision-making domain, we explored the following: (1) considerations around the decision to stop screening, (2) reactions if their clinician were to recommend that they stop
Key Points
Question How do older adults think about stopping cancer screening when life expectancy is limited, and how do they prefer to discuss it with clinicians?
Findings In this qualitative interview study with 40 community-dwelling older adults, participants were amenable to stopping cancer screening in the context of a trusting relationship with their clinician. Participants did not often consider life expectancy important in screening or prefer to hear about life expectancy when discussing screening.
Meaning Better delineating patient-centered approaches to discuss screening cessation when life expectancy is limited is important for optimizing cancer screening in older adults.
screening, (3) perceived importance of health and functional status (important predictors of life expectancy) in screening decisions, 34, 35 and (4) views on hypothetical examples about screening when age and health status were discordant.
In the communication domain, we tested 4 communication strategies for clinicians to discuss screening cessation to a hypothetical patient (Box 1). We then explored attitudes on discussing life expectancy in the cancer screening context. We asked participants for their reaction to one of the Choosing Wisely statements that address cancer screening and limited life expectancy. [13] [14] [15] [16] We presented the statement from the Society of General Internal Medicine owing to its brevity: "Don't recommend cancer screening if patient is not likely to live 10 years." 16 The interviews were semistructured and allowed for new topics to emerge.
Questionnaire
A structured questionnaire prior to the interview collected information on demographic characteristics, health, and functional status as part of a mortality risk index, 34 health literacy, 36 numeracy, 37 and trust in the clinician ("All in all, you have complete trust in your doctor"; 1 = strongly disagree, 5 = strongly agree). 38 We also asked about past screenings for breast (women only), prostate (men only), colorectal cancers, and intention to continue or discontinue screenings at the time of the study. We extracted information on health conditions and duration of relationship with clinician from the medical records. Using the collected data, we estimated 4-year and 10-year mortality risks using a validated index. 
Results
Forty older adults participated in the study ( participants (all female) reported that they had decided to stop screening and 4 participants (2 males, 2 females) reported that they were unsure about continued screening. Qualitative content analysis revealed 3 major themes with subthemes (Box 2); these are presented herein and illustrated using representative quotes.
Theme 1: Amenable to Considering Screening Cessation
Reasons to Stop Screening Older adults were amenable to considering cessation of cancer screening. In addition to the participants who already decided to stop screening, others mentioned hypothetical scenarios in which they would consider screening cessation ( Table 2) . Older age was the most common reason; one 84-year-old woman said: "I just feel like at my age I don't need a colonoscopy, what's gonna be is gonna be."
The mentioned age threshold to stop screening varied in age from 65 to 100 years.
Cessation of Screening and Trusting Relationship
When the participants were asked how they would react if their regular clinician suggested that they stop screening, many said that they would view such a suggestion as acceptable or positive. One participant said: "I'd feel good that I didn't need [ we don't have to do this no more I'd say: 'thank you very much doc'… I probably [would] think more of him." Another participant said, "I would think he would be personalizing my personal health when he suggested that." Many of the participants attributed their responses to their trust and confidence in their clinician: "I have all the confidence in her and if she told me to stop it I would stop." Some participants were skeptical of a suggestion to stop screening or said that they would still insist on screening. Even among these, participants mentioned that the clinician's suggestion would not necessarily make them think less of the clinician or trust the clinician less. One person described that she even- Importance of Health Status Older adults supported using health status to individualize screening decision but often did not understand the role of life expectancy. When asked about the importance of health and functional status in cancer screening decisions, most participants believed that these were important factors to consider along with age: "There are people much younger whose health is very poor, and people who are 80 and 90 whose health is very good, so age is not the only determining factor [in cancer screening] in my opinion."
Health Status and Screening Decisions
On the one hand, when provided the example of a healthy older person who would have been recommended to stop screening based on age, many participants supported continuation of screening. On the other hand, when provided the example of a sick younger person who would have been recommended to receive screening based on age, many agreed that foregoing screening made sense: "Don't do it.
[Cancer] isn't a Twenty-nine of 40 participants were up to date for at least 1 type of screening (breast, prostate, colorectal).
b Screening by mammography within the past 2 years. Five women were ineligible for screening owing to history of breast cancer or mastectomy.
c Screening by prostate-specific antigen test within the past 2 years. Three men were ineligible for screening owing to history of prostate cancer.
d Screening by colonoscopy within the past 10 years.
e A median life expectancy of more than 10 years is defined as a less than 50% mortality risk over 10 years; a median life expectancy of 4 to 10 years is defined as a 50% or greater mortality risk over 10 years and a 50% or lower mortality risk over 4 years; a median life expectancy of less than 4 years is defined as a greater than 50% mortality risk over 4 years. Participants mentioned several reasons to stop screening.
Cessation of screening was acceptable within trusting relationship.
Theme 2: Older adults supported using health status to individualize screening decision but often did not understand the role of life expectancy. Subthemes:
Health status was considered important.
Some used health status in different ways to inform screening decisions.
Many did not understand the role of life expectancy in cancer screening.
Theme 3: Preferences varied regarding how to discuss cessation of screening. Subthemes:
Incorporating health status was the preferred communication strategy.
Views were divided on whether life expectancy should be discussed.
Specific wording of life expectancy was important.
Some preferred little to no explanation.
gonna be the thing that kills the people if they've got all those [health] problems." For some participants, however, using health status to inform screening decision led to opposite conclusions. Despite explaining that screening by definition looks for cancer in the absence of symptoms, some participants viewed screening as a way to evaluate poor health: "If a person is sick all the time any test they do has got to help, it can't hurt … if they were really sick they'd probably need more tests."
The Role of Life Expectancy in Cancer Screening Although many participants supported using health status, along with age, to inform the screening decision, they did not perceive life expectancy as being directly related to health status and age and were perplexed when shown the Choosing Wisely statement "Don't recommend cancer screening if patient is not likely to live 10 years." 16 All except 2 participants objected or questioned the statement. Reasons for objection included skepticism about life expectancy predictions, skepticism about screening's lag-time to benefit, and perceived negativity of the statement ( Some participants mentioned that they would want to discuss what health issues, instead of cancer screening, would be the focus of their care. Others mentioned the importance of giving patient the ultimate choice to make the decision.
Views on Whether Life Expectancy Should be Discussed
Participants were divided about whether clinicians should mention life expectancy in the context of discussing cancer screening if the clinician's recommendation was informed by the patient's life expectancy. The most common reason for wanting to discuss life expectancy was full disclosure of information: "I would want to know. [There are] a lot of things in life that is upsetting but you deal with it. It's better, I think it's better, to know than to not know." For another participant, the phrase that "the test is not going to help you live longer" was the most compelling reason to stop screening: "That would really make me think and probably change my mind [about continuing screening]."
Others did not want to hear about life expectancy in the context of cancer screening: "Even though the doctor may have the feeling that the patient is not going to live very long I don't think he should express it… No, just say the test is not going to be helpful."
A common reason was that the participants did not believe that clinicians can predict life expectancy: "A doctor cannot tell you how long you gonna live, he can't tell you if you gonna die tomorrow, next week, or 10 years from now…the only one [who] knows about that is God."
A second reason that participants did not think life expectancy should be discussed in cancer screening was that the information would depress or worry the patient: "I would rather for them to focus on the test because to tell me about life expectancy then my mind is gonna be: 'oh, I'm not gonna live long.' You could shut a person down quicker."
Specific Wording of Life Expectancy
We provided 2 example phrases that mentioned life expectancy to explain screening cessation: "This test would not help we characterized perspectives from older adults with a wide range of life expectancies regarding cancer screening cessation when life expectancy is limited. To our knowledge, this is the first project to describe older adults' preferences for different strategies to discuss screening cessation.
Contrary to previous studies that suggested that patients may be reluctant to stop screening, [23] [24] [25] [26] [27] we found that many participants in our study were amenable to considering screening cessation. Recommendations from a trusted clinician made screening cessation acceptable or positive to our study participants, whereas most participants in prior studies stated that they had never discussed stopping cancer screening with their clinicians. 24, 25 The results also contrast with a study that suggested a recommendation to stop screening may undermine trust in the clinician. 24 The difference in results may stem from the fact that our study participants had high levels of trust and long relationships with their clinicians. Our results need to be tested in larger populations but suggest that it is possible for clinicians to find acceptable ways to recommend screening cessation without negatively affecting their on-going relationship with the patient. We found that many participants agreed that age and health status are important in screening decisions. While these factors are key predictors of life expectancy, 34,35 our participants did not perceive life expectancy as being directly related to them or that life expectancy itself was important in cancer screening. The perceived irrelevance of life expectancy was also found in 2 previous studies. 25, 26 It is not surprising then that many participants objected to the Choosing Wisely statement 16 about not recommending cancer screening in those with limited life expectancy. We realize that this statement is intended for clinicians and may have been worded differently if directly addressing patients. This result demonstrates that complex concepts and terms used in research and clinical guidelines, such as life expectancy, can be misinterpreted by the public and call for careful, sensitive discussions to avoid misperceptions. We found similar views among participants with varying predicted life expectancies. An important next step is to examine the potential heterogeneity in views by life expectancy in a larger study. Using health status to inform screening led to opposite decisions in some participants. These participants perceived someone with poor health status to need more screening. This misunderstanding of the purpose of screening, even after providing a brief explanation, confirms the importance to both educate patients and check for understanding in clinical practice.
How to best discuss screening cessation has not been previously studied. A systematic review of the impact of clinicianpatient communication on cancer screening showed that whether or not a clinician recommended screening only explained some of the screening behavior; the quality and content of the communication were also influential. 28 Currently, clinicians use a variety of approaches to discuss cessation of screening without clear best practices. 41 Our results add to the literature by showing that many participants preferred explanations that included individualized health status but disliked explanations that mentioned life expectancy with a negative framing ("you may not live long enough to benefit from this test"). Our findings highlight a potential dilemma around incorporating life expectancy in cancer screening. Although many participants were receptive to stopping cancer screening, most did not feel that life expectancy was the key decision-making factor, were skeptical that clinicians could accurately assess life expectancy, and did not want the clinician to discuss life expectancy in the screening context. An important implication of this finding is that clinicians may be caught between, on the one hand, patients who do not believe or want to hear about life expectancy, and, on the other hand, research and guidelines that emphasize the importance of using life expectancy to inform cancer screening. [3] [4] [5] [6] [13] [14] [15] [16] The scientific literature increasingly recognizes the importance of incorporating patient preference into clinical guidelines, including in the language of guideline presentation. 42, 43 Our results need to be tested in larger populations but suggest that misperceptions around the term life expectancy may be a barrier to guideline acceptance; a different term to represent the predicted health trajectory based on age and health status may be more preferred by patients. Even if the role of life expectancy in cancer screening is appropriately understood, the participants' questions about the accuracy of life expectancy estimates may remain, since inherent uncertainty exists in applying population-based prediction models to any individual. A threshold of 10-year life expectancy may not sufficiently account for this uncertainty. Patient input is important to help better define how to apply life expectancy predictions to guide cancer screening decisions. These implications are also relevant to a number of other clinical decisions that incorporate life expectancy.
44,45
Limitations
This study has several limitations. It was conducted with participants from clinical programs affiliated with 1 academic center and all participants had regular clinicians in whom they had high levels of trust. The results may not represent experiences of older adults elsewhere or among those without regular clinicians. This study was not designed to be representative of all older adults, but rather to gain in-depth perspectives about a topic about which little was previously known. There was only 1 interviewer, and both transcript coders were physicians which may have had an impact on data collection and interpretation. The study design relied on self-report, and the results are prone to recall and social desirability biases. A number of the interview questions used hypothetical scenarios, and participants' responses may not be fully congruent with behavior in real life.
Conclusions
We found that older adults were generally receptive to recommendations to stop cancer screening, especially in the context of a trusting physician relationship and when the discussions framed the recommendations around age, health status, and helping people live longer; in contrast, discussing life expectancy in the screening context was more controversial. Testing these communication preferences in larger populations to better delineate patient-centered approaches to discuss screening cessation is an important step toward optimizing cancer screening in older adults. 
Invited Commentary
LESS IS MORE
Talking to Patients About Cancer Screening Cessation
Alexia M. Torke, MD, MS There has been a growing realization that many individuals who have advanced illness or multiple medical conditions continue to receive cancer screening that is unlikely to benefit them. Such screening tests may also cause burden owing to the cascade of interventions that follows a positive test result and the burdens of the tests themselves. This has led to an important movement to stop unnecessary cancer screening by considering risks and benefits for individual patients and communicating effectively with the patient when the benefits no longer outweigh the risks.
1,2 Screening guidelines are also beginning to consider when cancer screening should be individualized based on factors such as age, comorbidity, or life expectancy. Other guidelines note that evidence is insufficient to recommend a screening test for those older than a certain age. Public health efforts to promote screening for cancer have been highly effective in raising awareness of its importance. However, the positive messages about screening from clinicians and the media may pose a major challenge to reducing rates of unnecessary screening. Screening tests may also be prompted by form letters or postcards sent directly to a patient's home that may not be individualized based on factors such as advanced illness or age. Turning the tide on nonbeneficial testing will involve communicating effectively with patients and families to explain why, after years of hearing that screening is essential to health, the risks and benefits might have changed for the patient owing to advanced age or serious illness.
Prior research confirms that older adults view cancer screening very favorably and may even be suspicious of messages to stop. 3, 4 Unfortunately, there has been little evidence about aspects of communication that are effective and well received by patients when a screening test is no longer likely to be beneficial. The study by Schoenborn et al 5 published in this issue of JAMA Internal Medicine provides important new information about what older adults do want to hear and situations in which they would consider cessation of cancer screening. 5 The study found that many patients are amenable to stopping cancer screening in the context of a trusting relationship and when they hear messages addressing their own concerns, such as advancing age and declining health status.
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Interview Guide
We are interested to know your opinions about cancer screening. There is no right or wrong answer. Please do not feel like you have to answer in a certain way. 11. Because cancers grow slow, in people who may not live very long, research shows that the harms may be more than the benefit, so some guidelines have said things like:
"Don't recommend cancer screening if patient is not likely to live 10 years."
What is your opinion or reaction to that statement?
12. Is there anything else I haven't asked you about this topic that you would like to share?
